Association between dexamethasone treatment and alterations in serum concentrations of trace metals. 2020

K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
Department of Pharmacy, Kobe University Hospital, Kobe, Japan.

Previously, a significant elevation in the serum levels of iron (Fe) was observed within a few days after the initiation of cisplatin (CDDP)-based chemotherapy. To clarify the underlying mechanisms, the serum concentration of hepcidin, a negative regulator of Fe release, was determined in the clinical samples obtained from six patients with cancer. The result showed that the serum concentration of hepcidin in patients receiving CDDP-based chemotherapy was significantly increased after 4-6 days of treatment, in comparison to the baseline level, suggesting that aforementioned excessive systemic Fe was not explained by the change of serum hepcidin level. All these patients received antiemetic premedication. We next evaluated of the effects of Pt-containing drugs and prophylactic antiemetic dexamethasone medication on the serum concentration of trace metals in mice, and on the hepatic and renal concentration of trace metals. The serum concentrations of Fe, Cu, and Zn in the CDDP-treated and oxaliplatin-treated mice were not significantly altered in comparison to those of the vehicle-treated control group. The serum concentrations of Fe, Cu, and Zn were increased after 24 h of dexamethasone treatment, compared to those of the control group (P < 0.05). The hepatic concentration of Mn was significantly reduced, whereas those of Fe and Cu inclined to diminish. The present findings suggest that dexamethasone can partly contribute to the changes in the serum concentrations of trace metals during anticancer chemotherapy.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
March 2023, Journal of occupational and environmental medicine,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
January 2022, Frontiers in public health,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
July 2014, Lupus,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
January 2022, Veterinary medicine international,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
October 2015, JAMA ophthalmology,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
July 2015, Nutrients,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
August 2002, Toxicology letters,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
September 2015, Biological trace element research,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
November 2012, Endocrine connections,
K Yamashita, and T Ogihara, and M Hayashi, and T Nakagawa, and Y Ishizaki, and M Kume, and I Yano, and R Niigata, and J Hiraoka, and H Yasui, and T Nakamura
December 1982, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!